Taiwan FDA registration 5d1c157086927d3af744fc9bd6993291
Taifu–Mei drug tube liquid
TW: 台富–梅毒品管液
Taiwan·Risk Class 2·Taiwan Fu Pharmaceutical Co., Ltd·Registered Apr 15, 2021 – Apr 15, 2026CancelledRegistration details
- Analysis ID
- 5d1c157086927d3af744fc9bd6993291
Company information
- Manufacturer
- Taiwan Fu Pharmaceutical Co., Ltd
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- Taiwan Fu Pharmaceutical Co., Ltd
Product details
- Intended Use
- 𑁁aseroDIA-YSERODIA-YSERODIA - YSERODIA -YSERODIALse G TP–NSAs 1,000,000 I'd like to see the rest of the world.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1660 Quality control materials (analytical and non-analytical)
- Import Information
- 國產;; QMS/QSD
Dates and status
- Registration Date
- Apr 15, 2021
- Expiry Date
- Apr 15, 2026
- Cancellation Date
- Oct 28, 2022
Cancellation information
- Status
- Logged out
- Reason
- 公司歇業
About this record
Access comprehensive regulatory information for Taifu–Mei drug tube liquid in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 5d1c157086927d3af744fc9bd6993291 and manufactured by Taiwan Fu Pharmaceutical Co., Ltd. The authorized representative in Taiwan is Taiwan Fu Pharmaceutical Co., Ltd.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices